Below is a tweet from Adam Stern – physician, kidney cancer survivor, and now best selling author of Shrunk MD – a book of cartoons that he recently published. “I’m reaching out to anyone who has influenced me over the months since my own diagnosis and offering to send a copy to help raise money for @kcCURE.” When Adam came to us with the idea of selling his book as a fundr...
Driving the long trip from DC to our Kidney Cancer Patient Meeting in Chapel Hill, North Carolina last week, a song from Pink came on the radio: Walk me home in the dead of night I can’t be alone with all that’s on my mind, So say you’ll stay with me tonight ‘Cause there is so much wrong going on outside I couldn’t help but think about Kidney Cancer Awareness Month and the ...
During Kidney Cancer Awareness Month, visit us at KCCure each day, where we’ll share a new story from someone whose life has been touched by kidney cancer. We share Kidney Cancer Patient Stories to let others know that they’re not alone. One day, after talking to a kidney cancer patient on the phone, my daughter Josie asked me what we had been talking about. I said, “He has cancer, and...
If you or someone you care for has been diagnosed with kidney cancer, we encourage you to seek out help from others from any one of the amazing kidney cancer patient communities that exist. Whether you have stage 1 disease or stage 4 disease, there is a place of comfort for you. You are not alone!
Each day in March, visit us at KCCure, where we’ll share a new story from someone whose life has been touched by kidney cancer. We share Kidney Cancer Patient Stories to let others know that they're not alone.
New data from the pivotal phase 3 Checkmate 214 trial combining ipilumimab and nivolumab presented at the European Society of Medical Oncology (ESMO) conference in Madrid showed superiority for the combination over Sunitinib (Sutent). This data will likely mean that the IO combination will move to approval for first line stage 4 RCC therapy.
The Kidney Cancer Research Alliance (KCCure) announced today that their first research grant of $100,000 has been awarded to Dr. Wayne Marasco, at Dana Farber Cancer Center for his proposal: CAR T-Cell Factories that change the Tumor Microenvironment to Achieve RCC Cures.
For our part, in honor of World Kidney Cancer Day – we are proud to announce that our first grant of $100,000 is being awarded to Dr. Wayne Marasco at Dana Farber Cancer Center for his continuing efforts to translate CAR T-Cell Therapy into a new treatment for kidney cancer.
As members of the International Kidney Cancer Coalition (IKCC), KCCure is a proud partner and participant of the first-ever World Kidney Cancer Q&A Day. On June 22, 2017, patients, caregivers, health care professionals and local organizations from around the world will join together to raise awareness about kidney cancer.
Help us improve surveillance in kidney cancer by taking the KCCure kidney cancer survey
It's hard to believe how far we've come as an organization in less than one year since our launch. This week, marked another milestone as KCCure was represented, for the first time, at the International Kidney Cancer Coalition Conference (IKCC) in Warsaw, Poland.
Laura tells KCCure about her diagnosis with stage 4 papillary kidney cancer and how she now has No Evidence of Disease (NED) from the treatment Cabozantinib. This is her story.